Net Income

After a 39% stock crash, Lakeland Industries' former CFO is sued over allegedly misleading investors about the company's deteriorating financial health.

Dallas Nephrology Associates earns its second Burl Osborne Award, a testament to its sustained, innovative commitment to fighting kidney disease in Texas.

With a 7.7% return and 109% funded status, HOOPP secures pensions for 500,000+ healthcare workers while boosting Canada's economy.

Petcurean launches a groundbreaking pet food combining dental and immune support, backed by clinical trials and poised to disrupt the premium market.

The engineering giant saw strong revenue growth in 2025, fueled by its nuclear focus, but one-off costs and investment writedowns hit its bottom line.

Nashville's Peg Leg Porker launches 'Spirit of America' bourbon, blending founder's resilience with Bottled-in-Bond quality for the nation's 250th.

The independent New Mexico resort is challenging industry norms by including free Pass Assurance with its new, benefit-rich 2027 season pass lineup.

From permanent Nacho Fries to a Crème Brulee Crunchwrap, Taco Bell's star-studded Peacock special reveals a bold, risky strategy for the future of fast food.

As millions of EV drivers plan spring road trips, they face a new reality of range planning, charging gaps, and rising insurance costs.

A new pilot in South Africa will test foldable shipping containers that could slash costs, cut emissions, and revolutionize the global freight industry.

Kyocera unveils a PCIe 6.0 optical module, promising to slash power use and boost speed in AI data centers, entering a fierce race for the future of compute.

Forbes' 40th list reveals 3,428 billionaires worth a record $20.1T, as an AI market surge pushes Elon Musk's fortune to an unprecedented $839 billion.

The industrial giant earns top global ESG ratings for the third straight year, proving that strategic sustainability drives both environmental impact and investor value.

The newly independent Pittsburgh Paints Co. unveils its comprehensive TRU-INDUSTRIAL line, aiming to become a single-source supplier in a competitive market.

In a move to solve AI's data quality problem, RavenPack is integrating EIU's 80 years of global intelligence into its platform for financial institutions.

Following a major investment, Trialbee appoints a seasoned leader to its board, signaling a push for dominance in AI-driven clinical trial recruitment.

A new analysis shows AI platforms can cut hospital costs by $2M annually while reducing ICU stays and ventilation time, transforming critical care.

Amid Europe's market comeback, DWS launches the XEML ETF, offering a targeted way for U.S. investors to tap into the continent's top 40 companies.

An Alabama firm's key regulatory filing for a critical drug component could accelerate the development of cheaper cancer supportive care biosimilars.

With a network reaching 1.2M providers, ConnectiveRx is embedding pharma messaging into clinical workflows. Is it the future of patient care or a new frontier of commercial influence?